Literature DB >> 2700569

Hypoglycemia in diabetes among children and adolescents.

M M Karp.   

Abstract

Hypoglycemia is one of the most common early complications in insulin-dependent diabetes mellitus (IDDM). Hypoglycemia in children may be considered a risk factor for brain damage and later intellectual impairment, and carries with it a high degree of child and parental anxiety. Recent studies have shown that in IDDM patients, and especially in those on intensive therapy, there is a defect in glucose counter-regulation, increased frequency of hypoglycemic episodes, loss of hypoglycemic awareness and responsiveness. Autonomic neuropathy, glucagon deficiency and low catecholamine response were implied in the pathogenesis of these disorders. In addition, uncontrolled IDDM patients show hypoglycemic symptoms at a higher blood glucose level. These recent observations may suggest that attempts to improve metabolic control may increase the risk of severe hypoglycemia. If so, some alterations in our therapeutic goals must be considered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2700569     DOI: 10.1007/BF02776472

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  25 in total

1.  Fear of hypoglycemia: quantification, validation, and utilization.

Authors:  D J Cox; A Irvine; L Gonder-Frederick; G Nowacek; J Butterfield
Journal:  Diabetes Care       Date:  1987 Sep-Oct       Impact factor: 19.112

2.  Crisis intervention program in newly diagnosed diabetic children.

Authors:  A Galatzer; S Amir; R Gil; M Karp; Z Laron
Journal:  Diabetes Care       Date:  1982 Jul-Aug       Impact factor: 19.112

3.  Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.

Authors:  Y Schottenfeld-Naor; A Galatzer; M Karp; Z Josefsberg; Z Laron
Journal:  Isr J Med Sci       Date:  1985-10

4.  Influence of sympathetic nervous system on hypoglycaemic warning symptoms.

Authors:  S R Heller; I A Macdonald; M Herbert; R B Tattersall
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.

Authors: 
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

6.  Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus.

Authors:  I Mühlhauser; M Berger; G Sonnenberg; J Koch; V Jörgens; G Schernthaner; V Scholz; D Pädagogin
Journal:  Diabetes Care       Date:  1985 May-Jun       Impact factor: 19.112

7.  Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.

Authors:  S A Amiel; R S Sherwin; D C Simonson; W V Tamborlane
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

8.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

9.  Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.

Authors:  G Bolli; G Calabrese; P De Feo; P Compagnucci; G Zega; G Angeletti; M G Cartechini; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

10.  Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.

Authors:  I Mühlhauser; I Bruckner; M Berger; D Cheţa; V Jörgens; C Ionescu-Tîrgovişte; V Scholz; I Mincu
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

View more
  3 in total

1.  Enhanced [3H] glutamate binding in the cerebellum of insulin-induced hypoglycaemic and streptozotocin-induced diabetic rats.

Authors:  Anu Joseph; Remya Robinson; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2007-09-06       Impact factor: 5.046

2.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

3.  Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats.

Authors:  Roshni Baby Thomas; Shilpa Joy; M S Ajayan; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2013-08-22       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.